Sage Journals: Discover world-class research

Abstract

Medication errors involving look alike sound alike (LASA) medications have widely been recognized to contribute to patient harm. Oncology biosimilars are considered to be LASA medications and require additional measures for operational safety. The Cancer Care Alberta (CCA) Pharmacy Educators developed an education strategy to ensure operational and patient safety during the implementation phase for oncology biosimilars in Alberta, Canada. This resulted in a smooth adoption of oncology biosimilars. As future oncology biosimilars are introduced, this framework will serve as the foundation to educate and train oncology pharmacy staff.

Keywords

Get full access to this article

View all access options for this article.

References

Frazer

Bubalo

Patel

, et al. International society of oncology pharmacy practitioners global position on the use of biosimilars in cancer treatment and supportive care. J Oncol Pharm Pract 2020; 26: 3–10.

Cook

McGrath

Dixon

, et al. Academic oncology clinicians’ understanding of biosimilars and information needed before prescribing. Ther Adv Med Oncol 2019; 11: 1758835918818335–1758835918818312.

Health Canada. Biosimilar biologic drugs in Canada: fact sheet, www.canada.ca/en/health-canada/services/drugs-health-products/biologics-radiopharmaceuticals-genetic-therapies/applications-submissions/guidance-documents/fact-sheet-biosimilars.html (2019, accessed 23 March 2021).

Institute for Safe Medication Practices Canada Safety Bulletin. Look-alike/sound-alike drug names: can we do better in Canada? https://www.ismp-canada.org/download/safetyBulletins/ISMPCSB2004-02DrugNames.pdf (accessed 12 April 2021).

Institute for Safe Medication Practices. (2009, May, 21). Survey on LASA Drug Name Pairs: Who Knows What’s on Your List and the Best Ways to Prevent Mix-Ups? ISMP. https://www.ismp.org/resources/survey-lasa-drug-name-pairs-who-knows-whats-your-list-and-best-ways-prevent-mix-ups (accessed 7 April 2021).

Dobish

Shultz

Neilson

, et al. Worksheets with embedded checklists support IV chemotherapy safer practice. J Oncol Pharm Pract 2016; 22: 142–150.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.04 MB